Holcombe Grier

2PUBLICATIONS
23CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Oct 29, 2025
A Phase 2 Trial of RANKL Antibody, Denosumab, in Two Cohorts of Patients with Recurrent/Refractory Osteosarcoma, a Report from the Children's Oncology Group.

Katherine A Janeway, Alexander J Chou, Allen Buxton

|Aug 31, 2023
Long-Term Outcomes in Patients With Localized Ewing Sarcoma Treated With Interval-Compressed Chemotherapy on Children's Oncology Group Study AEWS0031.

Thomas Cash, Mark D Krailo, Allen B Buxton

Pageof 1